Article
13 Aug 2025
Continued Efforts To Onshore Pharmaceutical Manufacturing: FDA Announces New FDA PreCheck Program
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
04 Jul 2025
Everything's Bigger In Texas — Including Its Regulation Of Ultra-Processed Foods
Article
01 Jul 2025
FDA Issues Final Guidance Addressing Remote Regulatory Assessments
Article
06 Jun 2025
UPFs Unwrapped: The Rise Of Ultra-Processed Food Scrutiny
Article
30 May 2025
FDA Promises To Support Efforts By States And Indian Tribes To Develop Successful Section 804 Importation Program Plans
Article
20 May 2025
Former FDA Officials Howard Sklamberg And Eva Temkin Share Insights On AI's Role In Drug Development On FDA Watch Podcast
Article
14 May 2025
President Trump Issues Executive Order On Regulatory Relief To Promote Domestic Production Of Critical Medicines
Article
11 Apr 2025
Navigating FDA Compliance And Civil Litigation: Strategies For Food And Medical Product Companies (Video)
Article
25 Feb 2025
MAHA And Its Possible Effects On The Food Industry
Article
18 Feb 2025
The DOGE Workforce Optimization EO: Implications For FDA
Article
28 Jan 2025
Howard Sklamberg Discusses FDA's Ban On Red Dye No. 3 On Public Health On Call Podcast
Article
28 Jan 2025
FDA Issues New Guidance On Current Good Manufacturing Practices For Drugs
Article
22 Jan 2025
FDA's Proposed Front-of-Package Nutrition Label Rule Reinforces Government Focus On Nutrition
Article
16 Jan 2025
FDA Finalizes Guidance On Notifying FDA Of A Permanent Discontinuance Or Interruption In Device Manufacturing Under Section 506J Of The FD&C Act
Article
09 Jan 2025
The Food And Drug Administration's Updated Definition Of "Healthy" And Other Changes To Food And Nutrition Regulations
Article
30 Oct 2024
Exemptions And Inspections: New Developments In DSCSA Compliance
Article
25 Jun 2024
Final Rule On Cannabis Rescheduling Could Publish In Fall 2024, Sklamberg Says
Article
29 May 2024
The Rescheduling Of Cannabis: What It Means, Next Steps, And Implications For Industry
Article
16 May 2024
Sklamberg Discusses Cannabis Rescheduling On NPR's 1A Podcast
Article
16 Apr 2024
FDA Publishes Final Guidance On Reporting Listed Drug Amounts
